Oral Prednisolone for Acute Rhinovirus Induced Wheezing in Children Less Than 2 Years of Age
ConditionBronchiolitis Acute Viral
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age6-24
SponsorUniversity of Oulu
About this trial
The aim of the trial is to evaluate whether the use of oral prednisolone directed by point-of-care testing is useful in acute wheezing caused by rhinovirus in children aged 6-24 months.
Eligibility criteria
Qualifiers
Wheezing bronchitis diagnosed by a physician
Need for salbutamol treatment at the emergency department
Positive nasopharyngeal rhinovirus or picornavirus finding in point-of-care testing
Disqualifiers
Need for immediate resuscitation
Immediate transfer to ICU
Suspected pneumonia based on the auscultation finding
Suspected serious bacterial infection
Trial design
Treatments tested in this trial
- Prednisolone Sodium Phosphate
- Sugar syrup
Treatment groups
210 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov